MENU
+Compare
IVA
Stock ticker: NASDAQ
AS OF
Oct 8, 04:59 PM (EDT)
Price
$5.25
Change
-$0.27 (-4.89%)
Capitalization
822.43M

IVA Inventiva SA Forecast, Technical & Fundamental Analysis

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation... Show more

IVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IVA with price predictions
Oct 07, 2025

IVA saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for IVA moved out of overbought territory on October 07, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 51 similar instances where the indicator exited the overbought zone. In of the 51 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for IVA moved out of overbought territory on September 02, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on October 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IVA as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for IVA turned negative on October 07, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IVA broke above its upper Bollinger Band on October 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where IVA advanced for three days, in of 236 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 146 cases where IVA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (23.421). P/E Ratio (0.000) is within average values for comparable stocks, (54.441). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.237). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (30.581) is also within normal values, averaging (342.085).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
IVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IVA is expected to report earnings to fall 83.52% to -28 cents per share on November 21

Inventiva SA IVA Stock Earnings Reports
Q3'25
Est.
$-0.29
Q2'25
Missed
by $1.16
Q4'24
Missed
by $1.39
Q3'24
Missed
by $0.20
Q2'24
Missed
by $0.17
The last earnings report on September 29 showed earnings per share of -175 cents, missing the estimate of -60 cents. With 50.45K shares outstanding, the current market capitalization sits at 822.43M.
A.I. Advisor
published General Information

General Information

a company, which engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
50 rue de Dijon
Phone
+33 380447500
Employees
123
Web
https://www.inventivapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIIIX23.83N/A
N/A
Fidelity Advisor International Growth I
GCCSX33.81N/A
N/A
Gabelli Small Cap Growth C
IIVLX21.57N/A
N/A
Transamerica Small/Mid Cap Value C
AZEMX13.51N/A
N/A
Alger Emerging Markets Z
TEOOX10.84N/A
N/A
Transamerica Emerging Markets Eq R6

IVA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IVA has been loosely correlated with DRUG. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if IVA jumps, then DRUG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVA
1D Price
Change %
IVA100%
-11.54%
DRUG - IVA
44%
Loosely correlated
-1.30%
TVGN - IVA
37%
Loosely correlated
+14.35%
IVF - IVA
30%
Poorly correlated
-4.15%
OCGN - IVA
24%
Poorly correlated
-3.30%
GNTA - IVA
23%
Poorly correlated
-1.86%
More